All News

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

I walked my way through the Spartan Race in 2016, battled cancer later that year, and returned the the Spartan course in 2018.

While universal screening for Lynch syndrome is currently only recommended for patients with colorectal and endometrial cancers, a new study recently published in The American Journal of Surgical Pathology suggests this for patients with upper tract urothelial carcinoma, too.

Patients with head and neck cancer appeared to be receptive to lung cancer screening, according to recent research performed at the University of Iowa Hospitals and Clinics.

I'm using the lessons that cancer taught me to move forward in life.

Eva Moon shares nine habits for keeping a sense of humor when the going gets rough.

One expert shares advice for opening the line of communication between patients and health care providers, as well as their partners.

Exercise and nutrition are essential to improving a variety of facets revolving around the continuum of cancer — from prevention to diagnosis and treatment to survivorship care.

When mental health and cancer health merge

Choosing to connect with other patients doesn't come without loss, but the benefit of being empowered by others makes you a better patient and more impassioned survivor.

Cancer survivors learn to tunnel through the snow. We have a community to help us become stronger mentally and support us through the tough times.

Explaining what lymhedema feels like isn't always easy.

We spend so much time worrying what we can't control. What if we asked ourselves why and changed the thought process to worrying about only what we can control.

Imagine receiving two pieces of life-altering news in a matter of three days. One survivor not only experienced this, but came out the other side with a positive outlook and a humorous book, too.

From sugar to stress, are there really any lifestyle changes that can truly keep cancer at bay?

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.

The FDA has granted a priority designation to a supplemental new drug application (sNDA) for Imbruvica (ibrutinib) for use in combination with Gazyva (obinutuzumab) for the frontline treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

The amount of preventative medicines given during hospital admission may be associated with an increased amount prescribed at discharge – resulting in higher costs and an increased risk for drug-drug interactions in patients with advanced lung cancer.

As marijuana use continues to increase across the US – and become legalized in more states – understanding the potential negative health effects is paramount.

Patients with the disease reported increased feelings of stigmatization, and results also showed that patients are viewed or treated differently than those with other cancer types.

With this FDA action, Talzenna (talazoparib) is the second PARP inhibitor to be approved in the breast cancer space.

In the first such clinical trial in the United States, researchers will evaluate focused ultrasound to breach the blood-brain barrier

More than 20 percent of patients with non–clear cell renal cell carcinoma (RCC) had a germline mutation, of which half had the potential to direct systemic therapy.

Experts at Roswell Park Comprehensive Cancer Center discovered a way to assess if a kidney tumor is benign or malignant, potentially sparing many from having to undergo surgery.

Children who suffer from a highly aggressive and deadly type of brain tumor may have new hope when it comes to treatment options.

Memories of a modern day mastectomy

The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.

The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.

It's not ghosts and ghouls... it's a reminder of the past.

The National Comprehensive Cancer Network updated its Clinical Practice Guidelines to add two new options for the frontline treatment of patients with kidney cancer.